RIPK2 and ovarian cancer: Equally, NOD-1 protein was found to phosphorylate NF-κB by binding to the protein receptor that interacts with serine/threonine kinase 2 (RIPK2), enhancing the proliferative and invasive properties of ovarian cancer cell lines [46].